DAGENS CITAT

"As a consequence the value of the TB-403 drops to SEK 8 per share. At this moment we will lower our target from SEK 34 per share to SEK 25 per share, and expect the share to drop ca 25%." Pareto om Bioinvent. Aktien handlas i 5,75 kr -56%